Context Therapeutics
CNTX
CNTX
16 hedge funds and large institutions have $6.3M invested in Context Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.69M | |
| 2 | +$310K | |
| 3 | +$303K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$108K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.9K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$1.31M | |
| 3 | -$954K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$143K |
| 5 |
VF
Virtu Financial
New York
|
-$142K |